1.

Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era

2.

Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era

3.

Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era

1.

Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection

1.

Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium

2.

Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium

3.

Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium

1.

Pneumococcal serotypes in children in 4 European countries

1.

Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme

2.

Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme

3.

Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme

1.

Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme

1.

Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria

2.

Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria

3.

Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria

4.

Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria

5.

Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria

6.

Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria

7.

Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria

1.

Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria

2.

Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria

3.

Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria

1.

Serotype 19A and 6C account for one-third of pneumococcal carriage among Belgian day-care children four years after a shift to a lower-valent PCV

1.

Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV

2.

Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV

3.

Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV